Biotech Values

[medchal]

First you claim the markets are inefficient.  Then you want people to "determine a proper valuation for MNTA".  Why diddle around with "proper valuation" if an inefficient market is going to ignore it anyway?  I can't make money on the "proper valuation" of a stock; I can only make it on the market valuation.

For myself, I only care about a "proper valuation" (my perception or anyone else's) if it diverges very widely from the market valuation and appears susceptible to correction by a market that has some degree of efficiency.

Observation is far from a perfect guide, but it is miles away from "intuition".